SRL
UTHR icon

Scientech Research LLC’s United Therapeutics UTHR Stock Holding History

Scientech Research LLC’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,855
Closed -$904K – 746
2025
Q4 		$904K Sell
1,855
-1,292
-41% -$602K 0.57% 23
2025
Q3 		$1.32M Sell
3,147
-3,004
-49% -$1.01M 0.46% 24
2025
Q2 		$1.77M Buy
+6,151
New +$1.84M 0.43% 30
2025
Q1 		– Sell
-1,451
Closed -$512K – 831
2024
Q4 		$512K Buy
1,451
+158
+12% +$58.1K 0.14% 286
2024
Q3 		$463K Sell
1,293
-1,122
-46% -$379K 0.09% 389
2024
Q2 		$769K Sell
2,415
-37
-2% -$9.79K 0.16% 234
2024
Q1 		$563K Sell
2,452
-3,921
-62% -$885K 0.3% 113
2023
Q4 		$1.4M Buy
+6,373
New +$1.47M 1.4% 5

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Scientech Research LLC's UTHR Position: Q1 2026 in Review

Scientech Research LLC sold out of United Therapeutics (UTHR) in Q1 2026, closing a stake of 1,855 shares — an estimated $904K sold.

Scientech Research LLC first reported a position in UTHR in Q4 2023 and held it in 8 quarters. The position peaked at $1.77M in Q2 2025. 854 funds tracked by Wall St. Rank hold UTHR as of Q1 2026.

  • Scientech Research LLC reported no remaining United Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Scientech Research LLC sold 1,855 United Therapeutics shares in Q1 2026, an estimated $904K.
  • Scientech Research LLC first reported a position in United Therapeutics in Q4 2023 and held it in 8 quarters.
  • Scientech Research LLC's United Therapeutics position peaked at $1.77M in Q2 2025.
  • 854 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2026.

Based on Scientech Research LLC's 13F filing for Q1 2026, filed 15 May 2026.